SGLT2 inhibitor empagliflozin alleviates cardiac remodeling and contractile anomalies in a FUNDC1-dependent manner in experimental Parkinson’s disease-Reference-Cited by-同舟云学术

SGLT2 inhibitor empagliflozin alleviates cardiac remodeling and contractile anomalies in a FUNDC1-dependent manner in experimental Parkinson’s disease

Published:2023-09-07 Issue:1 Volume:45 Page:87-97
ISSN:1671-4083
Container-title:Acta Pharmacologica Sinica
language:en
Short-container-title:Acta Pharmacol Sin

Author:

Yu Wei,Wang Lin,Ren Wei-ying,Xu Hai-xia,Wu Ne N.,Yu Dong-hui,Reiter Russel J.,Zha Wen-liang,Guo Qing-dong,Ren Jun

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmacology,General Medicine

Link

https://www.nature.com/articles/s41401-023-01144-0.pdf

Reference56 articles.

1. Aburub A, Ledger SJ, Sim J, Hunter SM. Cardiopulmonary function and aerobic exercise in Parkinson’s: A systematic review of the literature. Mov Disord Clin Pr. 2020;7:599–606.

2. Cuenca-Bermejo L, Almela P, Navarro-Zaragoza J, Fernandez Villalba E, Gonzalez-Cuello AM, Laorden ML, et al. Cardiac changes in Parkinson’s disease: Lessons from clinical and experimental evidence. Int J Mol Sci. 2021;22:13488.

3. Piqueras-Flores J, Lopez-Garcia A, Moreno-Reig A, Gonzalez-Martinez A, Hernandez-Gonzalez A, Vaamonde-Gamo J, et al. Structural and functional alterations of the heart in Parkinson’s disease. Neurol Res. 2018;40:53–61.

4. Suri JS, Paul S, Maindarkar MA, Puvvula A, Saxena S, Saba L, et al. Cardiovascular/stroke risk stratification in Parkinson’s disease patients using atherosclerosis pathway and artificial intelligence paradigm: A systematic review. Metabolites. 2022;12:312.

5. Ren J, Porter JE, Wold LE, Aberle NS, Muralikrishnan D, Haselton JR. Depressed contractile function and adrenergic responsiveness of cardiac myocytes in an experimental model of parkinson disease, the mptp-treated mouse. Neurobiol Aging. 2004;25:131–8.

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mitochondrial calcium uniporter complex: Unveiling the interplay between its regulators and calcium homeostasis;Cellular Signalling;2024-09

2. Mitophagy in the Pathogenesis of Obesity-Associated Cardiovascular Diseases: New Mechanistic and Therapeutic Insights;Trends in Medical Research;2024-05-20

3. Canagliflozin inhibits PASMCs proliferation via regulating SGLT1/AMPK signaling and attenuates artery remodeling in MCT-induced pulmonary arterial hypertension;Biomedicine & Pharmacotherapy;2024-05

4. AP39 through AMPK-ULK1-FUNDC1 pathway regulates mitophagy, inhibits pyroptosis, and improves doxorubicin-induced myocardial fibrosis;iScience;2024-04

5. Regulation of mitophagy and mitochondrial function: Natural compounds as potential therapeutic strategies for Parkinson's disease;Phytotherapy Research;2024-02-14